ARCHIVES

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: Korsmeyer Wins Bristol-Meyers Squibb Award; Lichter Names President-Elect of ASCO

April 18, 1997

The March: Research Task Force Calls For $10 Billion For NCI In 5 Years

October 23, 1998

Program Announcement: Breast Cancer Research

May 28, 1993

In Brief: Willis Taylor New ACS President, Gerald Murphy President Elect, Robert Gadberry Bord Chairman

November 19, 1982

Breast Implants Lessen Ability Of Mammograms To Find Cancer

February 27, 2004

New Methods Uncover 1,800 RNAs Linked To Breast Cancer

December 30, 2011